AnaptysBio Inc (GB:0HFQ)

AnaptysBio (0HFQ) Financial Statements


AnaptysBio Financial Overview

AnaptysBio's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; AnaptysBio is scheduled to report earnings on November 9, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 1.37M$ 6.81M$ 1.29M$ 1.22M$ 970.00K
Gross Profit$ 1.37M$ 6.81M---
EBIT$ -44.41M$ -25.98M$ -27.37M$ -26.69M$ -31.40M
EBITDA$ -46.00M$ -25.37M$ -26.78M$ -26.11M$ -30.83M
Net Income Common Stockholders$ -44.26M$ -26.37M$ -33.50M$ -32.55M$ -36.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 431.15M$ 441.24M$ 442.97M$ 442.15M$ 505.62M
Total Assets$ 549.81M$ 610.38M$ 618.50M$ 603.85M$ 625.17M
Total Debt$ 19.06M$ 19.45M$ 19.84M$ 20.22M$ 20.60M
Net Debt$ -412.09M$ -421.79M$ -423.13M$ -421.93M$ -485.02M
Total Liabilities$ 360.70M$ 348.28M$ 340.88M$ 299.54M$ 294.42M
Stockholders Equity$ 191.09M$ 262.10M$ 277.62M$ 304.31M$ 330.75M
Cash Flow-
Free Cash Flow$ -24.74M$ -10.86M$ -17.80M$ -24.23M$ -21.07M
Operating Cash Flow$ -24.57M$ -10.69M$ -17.75M$ -24.15M$ -21.01M
Investing Cash Flow$ 85.40M$ 21.50M$ -32.43M$ -71.00M$ -312.91M
Financing Cash Flow$ -37.57M$ 1.95M$ 37.03M$ 432.00K$ 4.61M
Currency in USD

AnaptysBio Earnings and Revenue History

AnaptysBio Debt to Assets

AnaptysBio Cash Flow

AnaptysBio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis